Granted Patent
B2
US 7,053,230 · App. 10/663,061 · Granted May 30, 2006
Aspirin-triggered lipid mediators
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
Claims (4)
1. A compound having the formula:
wherein R is a hydrogen atom or a pharmaceutically acceptable salt, ester, B, or —OR forms an amide and wherein P is a protecting group.
2. A method for treating inflammation in a subject, comprising the step of administering to the subject a compound having the formula:
wherein R is a hydrogen atom or a pharmaceutically acceptable salt, ester, B, or —OR forms an amide and wherein P is a hydrogen atom or a protecting group, such that the patient is treated.
Assignments (4)
CONFIRMATORY LICENSE
Recorded Nov 11, 2024
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 069198/0420 →
CONFIRMATORY LICENSE
Recorded Apr 1, 2023
From: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 063198/0335 →
CONFIRMATORY LICENSE
Recorded Mar 20, 2023
From: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 063035/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 8, 2008
From: SERHAN, CHARLES N.; CLISH, CLARY B.
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 021062/0158 →
Continuity (4)
Provisional Application
6023881400
· Oct 6, 2000
Provisional Application
6018307800
· Feb 16, 2000